Sedana Financial Statements From 2010 to 2024

SEDANA Stock  SEK 12.84  0.30  2.39%   
Sedana Medical financial statements provide useful quarterly and yearly information to potential Sedana Medical AB investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Sedana Medical financial statements helps investors assess Sedana Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Sedana Medical's valuation are summarized below:
Sedana Medical AB does not presently have any fundamental trend indicators for analysis.
Check Sedana Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sedana Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sedana financial statements analysis is a perfect complement when working with Sedana Medical Valuation or Volatility modules.
  
This module can also supplement various Sedana Medical Technical models . Check out the analysis of Sedana Medical Correlation against competitors.

Sedana Medical AB Company Return On Equity Analysis

Sedana Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Sedana Medical Return On Equity

    
  -0.0689  
Most of Sedana Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sedana Medical AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Sedana Medical AB has a Return On Equity of -0.0689. This is 99.71% lower than that of the Healthcare sector and 98.85% lower than that of the Medical Instruments & Supplies industry. The return on equity for all Sweden stocks is 77.77% lower than that of the firm.

Sedana Medical AB Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sedana Medical's current stock value. Our valuation model uses many indicators to compare Sedana Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sedana Medical competition to find correlations between indicators driving Sedana Medical's intrinsic value. More Info.
Sedana Medical AB is rated second in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sedana Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sedana Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Sedana Medical Financial Statements

Sedana Medical stakeholders use historical fundamental indicators, such as Sedana Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sedana Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sedana Medical's assets and liabilities are reflected in the revenues and expenses on Sedana Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sedana Medical AB. Please read more on our technical analysis and fundamental analysis pages.
Sedana Medical AB , a medical technology company, develops, markets, and sells medical devices in Sweden and internationally. Sedana Medical AB was founded in 2005 and is headquartered in Danderyd, Sweden. Sedana Medical operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 72 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Sedana Stock

Sedana Medical financial ratios help investors to determine whether Sedana Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sedana with respect to the benefits of owning Sedana Medical security.